{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-064279","form_type":"8-K","ticker":"INVX","cik":"0001042893","company_name":"Innovex International, Inc.","filed_at":"2026-02-23T23:59:59+00:00","discovered_at":"2026-05-14T18:02:34.449328+00:00","generated_at":"2026-05-16T01:01:44.936528+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Innovex Q4 revenue $274M, up 14% QoQ; full year net income $83M vs $140M prior year","bullets":["Q4 revenue $274M, up 14% sequentially; net income $14M, margin 5%.","Adjusted EBITDA $52M in Q4 (19% margin); full year $188M vs $139M in 2024.","Free cash flow $43M in Q4, $156M for full year 2025; conversion 83% of Adj. EBITDA.","Ended year with $203M cash and no bank debt; ROCE 10% for full year.","Completed tenth XPak installation in Brazil; exiting legacy Eldridge facility by Q2 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-064279","json":"https://secwatch.observer/filing/0001193125-26-064279.json","markdown":"https://secwatch.observer/filing/0001193125-26-064279.md","text":"https://secwatch.observer/filing/0001193125-26-064279.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1042893/000119312526064279/0001193125-26-064279-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1042893/000119312526064279/invx-20260223.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T01:01:44.936528+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}